Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Myomo, Inc. (MYO : AMEX)
 
 • Company Description   
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.

Number of Employees: 185

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.03 Daily Weekly Monthly
20 Day Moving Average: 2,397,489 shares
Shares Outstanding: 37.80 (millions)
Market Capitalization: $38.94 (millions)
Beta: 1.48
52 Week High: $7.17
52 Week Low: $0.80
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 18.39% 18.40%
12 Week -51.19% -53.20%
Year To Date -84.01% -85.88%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
45 Blue Sky Dr. Suite 101
-
Burlington,MA 01803
USA
ph: 617-996-9058
fax: -
ir@myomo.com http://www.myomo.com
 
 • General Corporate Information   
Officers
Paul R. Gudonis - Chief Executive Officer and Chairman
David A. Henry - Chief Financial Officer
Amy Knapp - Director
Thomas A. Crowley, Jr. - Director
Thomas F. Kirk - Director

Peer Information
Myomo, Inc. (BJCT)
Myomo, Inc. (CADMQ)
Myomo, Inc. (APNO)
Myomo, Inc. (UPDC)
Myomo, Inc. (IMTIQ)
Myomo, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 62857J201
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/05/25
Share - Related Items
Shares Outstanding: 37.80
Most Recent Split Date: 1.00 (0.03:1)
Beta: 1.48
Market Capitalization: $38.94 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.05 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.37 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.10
Price/Cash Flow: -
Price / Sales: 0.96
EPS Growth
vs. Year Ago Period: -266.67%
vs. Previous Quarter: -37.50%
Sales Growth
vs. Year Ago Period: 28.33%
vs. Previous Quarter: -1.83%
ROE
09/30/25 - -
06/30/25 - -50.87
03/31/25 - -35.57
ROA
09/30/25 - -
06/30/25 - -27.00
03/31/25 - -20.11
Current Ratio
09/30/25 - -
06/30/25 - 2.39
03/31/25 - 2.66
Quick Ratio
09/30/25 - -
06/30/25 - 2.03
03/31/25 - 2.37
Operating Margin
09/30/25 - -
06/30/25 - -22.87
03/31/25 - -15.05
Net Margin
09/30/25 - -
06/30/25 - -22.87
03/31/25 - -15.05
Pre-Tax Margin
09/30/25 - -
06/30/25 - -21.76
03/31/25 - -13.96
Book Value
09/30/25 - -
06/30/25 - 0.49
03/31/25 - 0.60
Inventory Turnover
09/30/25 - -
06/30/25 - 3.57
03/31/25 - 3.56
Debt-to-Equity
09/30/25 - -
06/30/25 - 0.08
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - -
06/30/25 - 7.03
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©